KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Return on Assets (2019 - 2025)

Vir Biotechnology (VIR) has disclosed Return on Assets for 7 consecutive years, with 0.43% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 7.0% to 0.43% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.43% through Dec 2025, down 7.0% year-over-year, with the annual reading at 0.36% for FY2025, 5.0% down from the prior year.
  • Return on Assets hit 0.43% in Q4 2025 for Vir Biotechnology, up from 0.45% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.5% in Q1 2022 to a low of 0.45% in Q3 2025.
  • Historically, Return on Assets has averaged 0.13% across 5 years, with a median of 0.28% in 2023.
  • Biggest five-year swings in Return on Assets: surged 88bps in 2022 and later plummeted -71bps in 2023.
  • Year by year, Return on Assets stood at 0.33% in 2021, then plummeted by -44bps to 0.19% in 2022, then plummeted by -265bps to 0.31% in 2023, then fell by -16bps to 0.36% in 2024, then fell by -20bps to 0.43% in 2025.
  • Business Quant data shows Return on Assets for VIR at 0.43% in Q4 2025, 0.45% in Q3 2025, and 0.44% in Q2 2025.